Director of Halozyme Therapeutics, Inc. (NASDAQ:HALO), Daly James M, sells 10,363 shares worth $418,800
According to Halozyme Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 25 06:57 PM, company Director, Daly James M disclosed selling 10,363 shares at a cost of $40.41. At the time of this transaction (Nov 25), this trade was worth $418,800 in total. As of Nov 25, Daly James M now owns 21,002 shares in total worth about $864,022.28.
For the last few recent trades made by Halozyme Therapeutics, Inc. (NASDAQ:HALO) Director, Daly James M, we have the following information:
- SEC Form 4 filing: Aug 13: Sold 34,337 shares at the rate of $29.12 per share. Total worth of this trade was $999,893. Total number of shares owned as of Aug 13 were 31,365
Posted by
George Daniels
on Thursday November 26 2020, 1:54 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
